Everest Medicines Marks a Milestone with First Patient Dosed for EVM16 Personalized mRNA Cancer Vaccine Everest Medicines has taken a significant step in cancer treatment with the first patient receiving EVM16, a personalized mRNA vaccine, at Peking University Cancer Hospital.

Everest Medicines Marks a Milestone with First Patient Dosed for EVM16 Personalized mRNA Cancer Vaccine #China #Beijing #Everest_Medicines #mRNA_Vaccine #EVM16